Author Question: Which is an important finding in outcomes research about Advanced Practice Nursing (APN) practice? ... (Read 41 times)

ghost!

  • Hero Member
  • *****
  • Posts: 560
Which is an important finding in outcomes research about Advanced Practice Nursing (APN) practice?
 
  a. APNs provide care that is equivalent to that provided by doctors at a fraction of the cost.
  b. Care by APNs shows equivalent or improved outcomes to that provided by physicians.
  c. Hospital readmission rates are slightly higher for patients who use APNs for primary care.
  d. The level of patient satisfaction is greater with APNs regardless of clinical outcomes.

Question 2

Which is one of the indicators used by the National Database of Nursing Quality Indicators (NDNQI)?
 
  a. Assessment, intervention, and reassessment of pediatric pain
  b. Clinical Laboratory Improvement Amendment (CLIA) standards
  c. Protocols for monitoring biometric equipment used in hospitals
  d. The number of hours hospital residents work per week



Sarahjh

  • Sr. Member
  • ****
  • Posts: 370
Answer to Question 1

ANS: B

Answer to Question 2

ANS: A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library